Membership
Empowering Your Career and Leadership Journey: On Demand
You are joining more than 40,000 industry professionals in investing in your career and leadership journey as we connect you to breaking news and the most relevant insights from the industry’s brightest minds and influencers to maximise your success. Health Industry Hub is the only one-stop-hub connecting professionals across the Pharma, MedTech and Biotech sectors to inspire meaningful change in healthcare and amplify opportunities for collaboration and innovation.
Read our client and community reviews here.
Top 3 Benefits
1. Stay informed: Timely access to breaking news and the latest trends delivered to your inbox to engage anytime, anywhere.
2. Competitive edge: On-demand podcasts, webinars and interviews with industry leaders and influencers to maximise performance.
3. Career advancement: Personalised and bite-sized learning for lifelong employability.
Ready To Invest In Your Success?
New Registrations
Register to enjoy the 14 days FREE trial. No credit card is required. After the trial period, please log in to your account, then subscribe below.
Corporate Subscriptions
Please contact us for a quote that meets the needs of your organisation. Tiered pricing benefits apply.
Existing Registrations with Expired Access
Please log in to your account, then subscribe below.
A tax invoice is provided should you wish to claim this professional development investment from your employer or during your annual tax return. The Health Industry Hub content is copyright protected and access is provided under individual user licenses for your personal use only. Please note our T&Cs and subscription terms of use.
News - Pharmaceuticals
Government tightens PBS chokehold: Earlier NOI deadlines add new access barriers to medicines
The government is once again moving the goalposts on the Pharmaceutical Benefits Scheme (PBS) access, this time by overhauling the […]
MoreNews - MedTech & Diagnostics
National project resetting the rules of AI in healthcare research
A multimillion-dollar national project is reshaping how artificial intelligence (AI) is ethically integrated into healthcare research. The initiative comes on […]
MoreNews - Pharmaceuticals
Novo Nordisk’s obesity drug faces fresh scrutiny as it heads back to the PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) will once again evaluate Novo Nordisk’s Wegovy (semaglutide), this time for patients with established […]
MoreNews - MedTech & Diagnostics
Tech-quity in action: NSW opens new hub for robotics, AI and digital health
NSW’s ambitions in robotic, AI, digital and remote healthcare have taken a major step forward with the launch of the […]
More